So there is a little bit of concern about that. Its a concern that has been pervasive enough for existing drugs that Lilly released a commercial ahead of the 2024 Oscars urging against vanity use
Bottom line: CagriSema could become the go-to option for patients who want more than Ozempic alone can offer, especially those struggling with fatty liver disease or stubborn appetite control
Initial Metabolic State People with conditions like insulin resistance, PCOS, or type 2 diabetes often take more time to see results
Strategics, too, are investing in and acquiring third-party manufacturers to strengthen supply chains and increase production capacity
Many GLP-1s are FDA approved for more than just weight loss, including type 2 diabetes, cardiovascular risk reduction, and even stroke prevention in certain populations, says Supriya Rao, MD, an obesity physician and the director of medical weight loss at Lowell General Hospital in Lowell, Massachusetts
OneTouch products for insulin dosing Abbott Diabetes Care FreeStyle Libre CGM systems Biodel Inc
